U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532824) titled 'Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS'... Read More
U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533539) titled 'Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD... Read More
U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533019) titled 'A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo' on April 09. Brie... Read More
U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07534657) titled 'A Study of JPH034 in Healthy Adult Participants' on March 17. Brief Summary: This study i... Read More
U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532629) titled 'Microbiome and Metabolome Profiles in Couples Undergoing IVF and Reproductive Outcomes' on... Read More
U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533929) titled 'Incidence and Predictors of Elevated ALT in Postpartum CHB Mothers' on April 09. Brief Su... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More